Shanghai Bao Pharmaceuticals Co., Ltd.
Status: Publicly traded
Direct answer
Shanghai Bao Pharmaceuticals Co., Ltd. is publicly traded on HKSE under the ticker 2659.HK.
Shanghai Bao Pharmaceuticals Co., Ltd., a biotechnology company, engages in the research, development, and commercialization of pharmaceutical products in Mainland China. The company uses synthetic biology technology to develop and deliver recombinant biologic drugs. Its products include KJ017, a recombinant human hyaluronidase for subcutaneous drug delivery; KJ103, a recombinant immunoglobulin G (IgG)-degrading...
Can you invest in Shanghai Bao Pharmaceuticals Co., Ltd.?
Yes. Shanghai Bao Pharmaceuticals Co., Ltd. trades publicly on HKSE as 2659.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Shanghai Bao Pharmaceuticals Co., Ltd.
Detailed equity research is provided by MarketSnap.